Herpes simplex encephalitis after receiving COVID-19 vaccine; a case report
Shortly after the onset of the coronavirus pandemic, different vaccines were developed to combat it. The vaccines had different mechanisms and triggered cellular and humoral immune responses against the virus. In addition to their positive effects, various side effects have been reported for them. They rarely cause severe complications. They can also rarely trigger latent infections. The present case report presents a patient who developed herpes simplex encephalitis after receiving the second dose of the Covaxin (BBV152).
2. Chiu HH, Wei KC, Chen A, Wang WH. Herpes zoster following COVID-19 vaccine: a report of three cases. QJM. 2021;114(7):531-2.
3. Sharun K, Dhama K. India's role in COVID-19 vaccine diplomacy. J Travel Med. 2021;28(7):taab064.
4. Pebody R, Andrews N, Brown D, Gopal R, de Melker H, Francois G, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80(3):185-91.
5. Moslemi M, Ardalan M, Haramshahi M, Mirzaei H, Sani SK, Dastgir R, et al. Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature. BMC Infect Dis. 2022;22:217.
6. Rabail R, Ahmed W, Ilyas M, Rajoka MSR, Hassoun A, Khalid AR, et al. The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization. Vaccines (Basel). 2022;10(4):488.
|Issue||Vol 6 No 4 (2022): Autumn (October)|
|Section||Case (report / study)|
|Adverse Effects BBV152 COVID-19 Vaccine COVID-19 COVID-19 Vaccines Encephalitis Herpes Simplex Vaccination|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|